Citation tools

Samant, Manoj, John Ziemniak, and John F Paolini. "First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell-Dependent Antibody Response." Journal of Pharmacology and Experimental Therapeutics (2023): JPET-AR-2023-001771. Web. 02 Oct. 2023.